HROW FY 2023 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$130M+47.0% YoY

Gross Profit

$91M69.6% margin

Operating Income

$431,0000.3% margin

Net Income

-$24M-18.7% margin

EPS (Diluted)

$-0.75

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$149M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$312M

Total Liabilities

$242M

Stockholders' Equity

$70M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$130M	$89M	+47.0%
Gross Profit	$91M	$63M	+43.3%
Operating Income	$431,000	$2M	-77.5%
Net Income	-$24M	-$14M	-73.3%